Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions.
“Asthma is a significant public health concern ... version of its chronic obstructive pulmonary disease (COPD) inhaler, Breztri. This new propellant, HFO-1234ze, boasts a near-zero global ...
Companies like AstraZeneca and GSK, which have high-revenue-generating inhalers for asthma and chronic obstructive pulmonary disorder (COPD) in their portfolios, have each committed to becoming ...